SCHEMBL415416

SCHEMBL415416

CCCC1(C(=O)c2cc3cc(F)ccc3n2S(=O)(=O)c2ccccc2)CCN(C)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOD2 Q9HC29 3/20 0.45
NOD1 Q9Y239 3/20 0.45
PTGDR2 Q9Y5Y4 3/20 0.41
PTGDR Q13258 2/20 0.41
SLC2A1 P11166 1/20 0.41
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
TSHR P16473 1/20 0.38
ACLY P53396 1/20 0.37
HTT P42858 1/20 0.37
HDAC3 O15379 2/20 0.37
HDAC4 P56524 2/20 0.37
HDAC1 Q13547 2/20 0.37
HDAC7 Q8WUI4 2/20 0.37
HDAC2 Q92769 2/20 0.37
HDAC10 Q969S8 2/20 0.37
HDAC11 Q96DB2 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17707489 0.92 NOD2 (0.44) NOD2NOD1PTGDR2PTGDRSLC2A1
SCHEMBL445020 0.86 NOD2 (0.42) NOD2NOD1PTGDR2PTGDRSLC2A1
SCHEMBL413982 0.80 PTGDR (0.39) NOD2NOD1PTGDR2PTGDRSLC2A1
SCHEMBL10003942 0.74 NOD2 (0.78) NOD2NOD1PTGDR2PTGDRALDH1A1
SCHEMBL1972137 0.73 PTGDR2 (0.40) NOD2NOD1PTGDR2PTGDRSLC2A1
SCHEMBL10003377 0.70 NOD2 (0.47) NOD2NOD1PTGDR2PTGDRSLC2A1
SCHEMBL415595 0.69 HRH4 (0.58) ALDH1A1KDM4EHPGDHSD17B10TSHR
SCHEMBL3560737 0.69 PTGDR2 (0.53) NOD2NOD1PTGDR2PTGDRALDH1A1
SCHEMBL443237 0.69 CYP2D6 (0.46) NOD2NOD1ALDH1A1HDAC3HDAC4
SCHEMBL442516 0.69 NR1H2 (0.40) NOD2NOD1PTGDR2PTGDRHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120065225-A1 HETEROARYL PYRROLIDINYL AND PIPERIDINYL KETONE DERIVATIVES AND USES THEREOF IYER PRAVIN (US) 2012-03-15 US disclosed
US-20090318493-A1 Aryl pyrrolidinyl and piperidinyl ketone derivatives and uses thereof ROCHE PALO ALTO LLC 2009-12-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120065225-A1 HETEROARYL PYRROLIDINYL AND PIPERIDINYL KETONE DERIVATIVES AND USES THEREOF CNKSR1, RB1, AR NOD2 1213/4885NOD1 1495/4885PTGDR2 1074/4885
US-20090318493-A1 Aryl pyrrolidinyl and piperidinyl ketone derivatives and uses thereof TPH2, TPH1, ADRA2C NOD2 1126/4885NOD1 1998/4885PTGDR2 391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.